We have investigated the factors that regulate aromatase activity in fetal-neonatal rat ovaries. Ovarian aromatase activity (assessed by measuring the amount of 3H20 formed from [1.3-3H]testosterone) is low prior to birth (<0.5
pmol/hr per mg of protein) and increases to values greater than 30 pmol/hr per mg of protein between days 8 and 12 after birth.
The appearance of ovarian aromatase (postnatal days 24) coincides with the development of primordial follicles. Fetalneonatal ovaries maintained in serum-free organ culture do not develop aromatase activity at the expected time. Ovine folliclestimulating hormone (0.1-1 pg/ml), ovine luteinizing hormone (0.1 pg/ml), or their combination failed to induce the enzyme activity in cultured fetal ovaries, whereas follicle-stimulating hormone is effective in preventing the decline in aromatase activity when postnatal day 8 ovaries are placed in culture. In contrast to follicle-stimulating hormone, dibutyryl-cAMP markedly enhances ovarian aromatase in cultured fetal ovaries. Likewise, enhancement of endogenous cAMP formation with forskolin or cholera toxin caused an increase in enzyme activity within 24 hr. Vasoactive intestinal peptide, a peptide known to occur in ovarian nerves, caused a dose-dependent increase in aromatase activity in fetal ovaries prior to folliculogenesis. Of related peptides tested, only the peptide having N-terminal histidine and C-terminal isoleucine amide was capable of inducing aromatase activity in fetal ovaries. The fact that VIP can induce aromatase activity in fetal rat ovaries prior to follicle formation and prior to responsiveness to follicle-stimulating hormone suggests that this neuropeptide may play a critical role in ovarian differentiation.
In many species, fetal ovaries acquire the enzymatic capacity to form estrogen from androgen (aromatase activity) during embryonic life (1, 2) . The significance of this endocrine differentiation is uncertain. Female phenotypic differentiation apparently does not depend on estrogen secretion from the fetal ovary (3), but estrogen might act locally to promote morphologic development within the ovary itself (4) . The fact that the endocrine differentiation of the tissue takes place during embryonic life (5) has made it difficult to study the factors that control the process.
Therefore, we have turned to the rat ovary. Although the ovaries of rats form estrogens in very low amounts during embryonic development (6, 7), the major development of ovarian aromatase occurs postnatally and is temporally associated with development of the follicles (8) . We document here that the postnatal appearance of rat ovarian aromatase does not occur spontaneously in culture but can be induced prior to folliculogenesis by activation of cAMPgenerating systems. Furthermore, vasoactive intestinal peptide (VIP), a neuropeptide that is found in ovarian nerves (9, 10) and has steroidogenic-promoting capacity in the gonads (10-13), can induce aromatase activity prior to folliculogenesis and prior to the acquisition of responsiveness to folliclestimulating hormone (FSH).
MATERIALS AND METHODS
Materials. [1f3-3H]
Testosterone was prepared and purified as described (14) to a specific activity of 18.6 Ci/mmol (1 Ci = 37 GBq). Cholera toxin, sodium butyrate, dibutyryl-cAMP (Bt2cAMP), dibutyryl-cGMP (Bt~cGMP), actinomycin D, 3-isobutyl-1-methylxanthine, and bacitracin were purchased from Sigma. Forskolin and cycloheximide were purchased from Calbiochem-Behring. Ovine luteinizing hormone NIDDK-oLH-24) and ovine FSH (NIDDK-oFSH-15) were provided by the National Institute of Diabetes, Digestive, and Kidney Diseases Pituitary Hormone Distribution Program. Antiserum to cAMP was purchased from Miles. VIP was initially obtained from A. J. W. Hsueh (Department of Reproductive Medicine, University of California, San Diego) and subsequently purchased from Peninsula Laboratories (San Carlos, CA). Porcine peptide having N-terminal histidine and C-terminal isoleucine (PHI), secretin, gastrointestinal peptide (GIP), growth hormone-releasing hormone (GRF), and motilin were also from Peninsula Laboratories. Penicillin/streptomycin solution and serumless medium (Neuman-Tytell) were from GIBCO. All other materials were from previously described sources (15) .
Animals. Timed-pregnant female Sprague-Dawley rats (Holtzmann, Madison, WI) were maintained in individual cages under controlled lighting (14 hr of light/10 hr of darkness) and temperature (230C) and were allowed free access to pelleted rat food (Teklad, Indianapolis) and tap water. The day on which sperm were detected in the vagina was considered day 1 of pregnancy. Gonads were dissected under aseptic conditions from fetal or newborn young at the times indicated and kept under aseptic conditions in ice-cold, serumless medium prior to culture or acute incubations.
Organ Culture. Gonads were cultured as described (5) . In brief, 1-8 ovaries or testes were maintained under 5% C02/95% air for 2 hr to 3 days at 370C at the atmosphere/ medium interface in serumless medium supplemented with 1% penicillin/streptomycin and 0.5 mM 3-isobutyl-1-methylxanthine. Unless indicated otherwise, all additions were made at the time the cultures were begun; media were not changed during the culture period. When the ovaries were cultured in the presence of peptides, bacitracin (20 ,uM) 
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Aromatase Assay. Aromatase activity was assessed by the 3H20 release method previously described (14 (23.7-24.7 pmol/hr per mg of protein) for the two substrates. Therefore, the standard assay conditions adopted for measuring aromatase activity in these experiments involved incubating gonads (1-8, depending on age; 0.02-0.05 mg of protein) for 1 hr at 370C in 0.1 ml of Eagle's minimal essential medium (pH 7.4)
cAMP Assay. Accumulation of cAMP in the culture medium was measured by RIA after acetylation of the samples as described (13, 16) . All samples were boiled for 10 min immediately after the end of the culture to destroy phosphodiesterase activity and stored at -20'C until assayed. The assay had a sensitivity of 4 fmol per tube, and the standard curve was linear between 4 and 500 fmol per tube.
Protein Determination. Protein was determined by the method of Lowry et al. (17) after overnight digestion of the tissue fragments in 0.5 M NaOH (15) .
Histology. Ovaries were fixed in buffered 10% formaldehyde, embedded in plastic, sectioned at 3 /im, mounted, and stained with hematoxylin/eosin.
RESULTS
Aromatase activity was barely detectable in the rat ovary until 2 days after birth, and the activity peaked between 8 and 12 days of life and returned to low levels by day 20 . In contrast, aromatase activity was not detectable in testes at any age studied (Fig. 1) . The appearance of aromatase activity in the neonatal ovary correlated closely with primary follicular development (Fig. 2) . On the expected day of birth (day 22 of fetal life), oocytes were distributed throughout the ovary in cortical cords; there was no evidence of follicle formation (Fig. 2a) . There was very little change in the histological appearance of ovaries obtained at postnatal day 2 ( Fig. 2b) , but by day 4 both primordial and primary follicles were identifiable (Fig. 2c) , and by day 8 the initial wave of primary follicular development was apparently complete (Fig. 2d) .
We examined the development of aromatase activity in ovaries maintained in organ culture. Aromatase activity in fetal ovaries obtained at the time of explant (day 22 of gestation) averaged about 0.5 pmol/hr per mg of protein, and by postnatal day 3 aromatase activity was -0.6 pmol/hr per mg of protein (Fig. 3 ng/ml), oLH (100 ng/ml), or the combination of the two hormones did not induce aromatase activity at this age (Fig.  3 Right). Similar results were obtained when 20% (5-day-old female) rat serum was added to the culture medium (results not shown). However, Bt2cAMP (1 mM) enhanced aromatase activity in vitro to a level greater than that seen in control ovaries at day 3 in vivo ( Fig. 3 Right) . The effect of Bt2cAMP was demonstrable at 0.1 mM and was maximal at 0.5 mM (data not shown).
In contrast, when ovaries were explanted on day 8 [a time when follicular development is unambiguous (Fig. 2d) and aromatase is maximal (Fig. 1) culture, aromatase activity declined from an initial f 28 pmol/hr per mg of protein to <2.0 pmol-hr per nug ein, but both Bt2cAMP (0.5 mM) and oFSH (1 pug/ml) ly prevented this decline (Fig. 4) . ,rovide insight into the initiation of ovarian aromatase I, we studied earlier embryos than in the previous nents (Fig. 5) . When day 19 fetal ovaries were cultured lays, aromatase activity was enhanced by 0.5 mM 4P to a greater extent than in day 22 ovaries. In testes, lase activity was not enhanced by Bt2cAMP at either eamined (Fig. 5) . Incubation of fetal ovaries with te (0.5 mM) or cGMP (0.5 mM) failed to enhance tase activity (results not shown), suggesting that the f Bt2cAMP is due to cAMP. To assess the validity of ference, the effect of endogenous increases in cAMP was evaluated. Both forskolin, a diterpene stimulator catalytic unit of adenylate cyclase (18) , and cholera which activates the guanine nucleotide-binding stim-( protein of the adenylate cyclase system (19), en-I aromatase activity in cultured fetal ovaries (results own). Actinomycin D (1 uM) and cycloheximide (1 ould block the induction of aromatase by forskolin in d fetal ovaries without inhibiting the increase in cAMP induced by this agent (Table 1) . a peptide associated with nerve endings in the ovary stimulates estradiol secretion by adult rat ovaries in 10) and by granulosa cells cultured from rat ovaries herefore, we assessed the effects of VIP on aromatase y in cultured fetal ovaries. VIP (1 uM) caused a want increase in both cAMP formation and aromatase y in 21-day fetal ovaries maintained in serumless m. This effect was demonstrable within 24 hr and was al at 48 hr (Fig. 6 ). Increases in both cAMP generation omatase activity were detectable at a VIP concentra-0.1 ,tM, and 1 gM VIP was as effective in enhancing tase as was 50 AM forskolin, even though VIPced cAMP formation was <5% that obtained with lin (Fig. 7) . VIP (1 uM) did not cause an increase in aromatase activity or cAMP formation in cultured fetal (Fig. 7) . To determine the specificity of the effect of VIP on aromatase activity, day 20 fetal ovaries were cultured for 48 hr in the presence of several related peptides of the glucagon family. VIP enhanced aromatase activity with an effectiveness similar to that of forskolin, and PHI, which shows substantial sequence homology with VIP (20) and interacts with the VIP receptor (21), was less effective than VIP. Other peptides examined, including secretin, GIP, glucagon, GRF, and motilin, were ineffective (Fig. 8) .
DISCUSSION
Although FSH is thought to be the major trophic hormone that controls follicular maturation at the time of sexual maturation (for reviews, see refs. 22 and 23), the factors that regulate the formation of primordial and primary follicles remain largely unknown (24, 25) . Indeed, specific binding of gonadotropins (FSH or LH/human chorionic gonadotropin) is not demonstrable in neonatal rat ovaries prior to days 4-5 (26, 27) , an observation that is in keeping with the belief that initial organization of both primordial and primary follicles is independent of the pituitary (24, 25) . Furthermore, despite the fact that gonadotropin levels are elevated throughout the first 2 weeks of life in the rat (28, 29) responsiveness of the ovary to gonadotropins in terms of cAMP formation (30, 31) and steroidogenesis (32) is delayed until at least postnatal day 4 (33) .
The postnatal development of primary follicles within the rat ovary correlates temporally with appearance of the ovarian aromatase enzyme. This coincidence of aromatase and follicular differentiation may be fortuitous, or the onset of estrogen synthesis could have a fundamental role in growth of the primary follicles and the subsequent development of ovarian responsiveness to gonadotropins (34) . Alternatively, aromatase activity may be a sensitive marker for the differentiation of primordial steroidogenic cells. In the hope of gaining insight into the factors that regulate primary follicular differentiation, we examined the regulation of aromatase activity in the neonatal rat ovary in culture.
In harmony with the observations showing that gonadotropins do not affect fetal-neonatal ovarian function, we found that FSH is ineffective in stimulating ovarian aromatase activity before formation of primary follicles. Failure of FSH action in the newborn ovary cannot be attributed to an intrinsic inability of the gland to respond to exogenous stimuli. Both the cAMP-generating system and the ovarian response to exogenous and endogenous cAMP appear to be operative by day 19 of fetal life as determined by the capacity of the gonad to respond to other stimulators of the cAMP regulatory machinery (such as forskolin or cholera toxin) with increased levels of aromatase activity. After formation of primary follicles, FSH is an effective stimulator of aromatase activity both in vivo (35) and in vitro (33, 35, 36) . As in other systems in which aromatase activity is inducible by cAMP-mediated processes (37) (38) (39) (40) , the increase in aromatase activity in fetal rat ovaries appears to reflect DNA- directed synthesis of new enzyme because it is blocked by both actinomycin D and cycloheximide.
In cultured granulosa cells, cAMP not only enhances and maintains FSH receptors (41) but also causes cell differentiation (42) . The role of cAMP-mediated mechanisms in primary follicular development is, however, unknown. Whether the development of primary follicles and their subsequent acquisition of responsiveness to FSH are events primarily dependent on the initiation of estrogen formation by prefollicular tissue or due to the induction by cAMP of a nonestrogenic mechanism is also unknown. However, a role for estrogen in these processes is suggested by the observation that estradiol enhances the effect of cAMP on the induction of FSH and LH receptors in cultured granulosa cells (43) .
The fact that VIP is capable of inducing aromatase activity in cultured ovaries before the initiation of folliculogenesis and responsiveness to FS14 suggests that it may play a role in the control of aromatase activity in prefollicular ovarian tissue. VIP can mimic many of the actions of FSH on granulosa cells including estrogen and progesterone release (10, 11) , enhancement ofthe synthesis ofcholesterol side-chain cleavage enzyme (13) , and acceleration of cAMP production (11, 13); but unlike FSH, it is incapable of inducing LH receptors (11) , suggesting that fundamental differences underlie the actions of the two hormones. Indeed, VIP appears to act on a subpopulation of granulosa cells different from those that respond to FSH (44) . VIP has also been reported to stimulate androgen biosynthesis in cultured neonatal rat testicular cells (12) , suggesting that it may be more generally involved in regulating steroidogenesis during development. In the neonatal rat ovary, VIP apparently activates a small percentage of the total adenylate cyclase while causing a maximal increase in aromatase.
Although our understanding of this phenomenon is still incomplete, these findings and the fact that VIP is present in ovarian nerves raises the possibility that the VIPergic innervation of the ovary plays a role-in the process ofpre-granulosa-cell differentiation and follicular organization. In addition, ovarian cells themselves may represent a source of VIP (45) during this early developmental phase. Noteworthy, recent electron microscopy studies have revealed the presence of nerves in fetal rat ovaries (S. Malamed and S.R.O., unpublished data). Moreover, VIP can be detected by RIA in the ovary as early as day 2 of postnatal development at concentrations as high as those found in juvenile rats (46) . Based on the aforementioned observations, one may visualize the onset of ovarian follicular development as regulated by the neuroendocrine system through two sequential mechanisms, an initial differentiation phase, which may be at least in part under VIPergic influence, and a subsequent phase of follicular growth that is predominantly under FSH (and LH) control. The validity of this hypothesis awaits experimental verification.
